Fludarabine with cytarabine followed by reduced-intensity
conditioning and allogeneic hematopoietic stem cell
transplantation in patients with poor-risk chronic lymphocytic
leukemia

J 2013

Fludarabine with cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with poor-risk chronic lymphocytic leukemia

KREJČÍ, Marta; Michael DOUBEK; Yvona BRYCHTOVÁ; Olga STEHLÍKOVÁ; Jana CHOVANCOVÁ et. al.

Basic information

Original name

Fludarabine with cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with poor-risk chronic lymphocytic leukemia

Authors

KREJČÍ, Marta (203 Czech Republic, guarantor, belonging to the institution); Michael DOUBEK (203 Czech Republic, belonging to the institution); Yvona BRYCHTOVÁ (203 Czech Republic, belonging to the institution); Olga STEHLÍKOVÁ (203 Czech Republic); Jana CHOVANCOVÁ (203 Czech Republic); Boris TICHÝ (203 Czech Republic, belonging to the institution); Hana SKUHROVÁ FRANCOVÁ (203 Czech Republic); Milan NAVRÁTIL (203 Czech Republic, belonging to the institution); Miroslav TOMIŠKA (203 Czech Republic, belonging to the institution); Ondřej HORKÝ (203 Czech Republic); Šárka POSPÍŠILOVÁ (203 Czech Republic, belonging to the institution) and Jiří MAYER (203 Czech Republic, belonging to the institution)

Edition

Annals of hematology, New York, Springer Verlag, 2013, 0939-5555

Other information

Language

English

Type of outcome

Article in a journal

Field of Study

30200 3.2 Clinical medicine

Country of publisher

United States of America

Confidentiality degree

is not subject to a state or trade secret

References:

URL

Impact factor

Impact factor: 2.396

RIV identification code

RIV/00216224:14740/13:00065704

Organization unit

Central European Institute of Technology

DOI

http://dx.doi.org/10.1007/s00277-012-1579-y

UT WoS

000313445100014

Keywords in English

chronic lymphocytic leukemia; reduced-intensity conditioning; fludarabine; cytarabine

Abstract

V originále

Allogeneic stem cell transplantation (SCT) is a treatment option for patients with poor-risk chronic lymphocytic leukemia (CLL).Sequential use of chemotherapy and reduced-intensity conditioning has been proposed to improve the treatment outcomes.

Links

ED1.1.00/02.0068, research and development project

Name: CEITEC - central european institute of technology

EE2.3.20.0045, research and development project

Name: Podpora profesního růstu a mezinárodní integrace výzkumných týmů v oblasti molekulární medicíny

FR-TI2/254, research and development project

Name: *Real-time PCR soupravy pro diagnostiku v onkologii (Acronym: ONKOKITY)

Investor: Ministry of Industry and Trade of the CR

MSM0021622430, plan (intention)

Name: Funkční a molekulární charakteristiky nádorových a normálních kmenových buněk - identifikace cílů pro nová terapeutika a terapeutické strategie

Investor: Ministry of Education, Youth and Sports of the CR, Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies

Files attached

EL_1082993_Fludarabine_with_cytarabine.pdf

Request the author's version of the file

Cite

KREJČÍ, Marta; Michael DOUBEK; Yvona BRYCHTOVÁ; Olga STEHLÍKOVÁ; Jana CHOVANCOVÁ; Boris TICHÝ; Hana SKUHROVÁ FRANCOVÁ; Milan NAVRÁTIL; Miroslav TOMIŠKA; Ondřej HORKÝ; Šárka POSPÍŠILOVÁ and Jiří MAYER. Fludarabine with cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with poor-risk chronic lymphocytic leukemia. Annals of hematology. New York: Springer Verlag, 2013, vol. 92, No 2, p. 249-254. ISSN 0939-5555. Available from: https://dx.doi.org/10.1007/s00277-012-1579-y.

@article{1082993,
   author = {Krejčí, Marta and Doubek, Michael and Brychtová, Yvona and Stehlíková, Olga and Chovancová, Jana and Tichý, Boris and Skuhrová Francová, Hana and Navrátil, Milan and Tomiška, Miroslav and Horký, Ondřej and Pospíšilová, Šárka and Mayer, Jiří},
   article_location = {New York},
   article_number = {2},
   doi = {http://dx.doi.org/10.1007/s00277-012-1579-y},
   keywords = {chronic lymphocytic leukemia; reduced-intensity conditioning; fludarabine; cytarabine},
   language = {eng},
   issn = {0939-5555},
   journal = {Annals of hematology},
   title = {Fludarabine with cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with poor-risk chronic lymphocytic leukemia},
   url = {http://www.deepdyve.com/lp/springer-journals/fludarabine-with-cytarabine-followed-by-reduced-intensity-conditioning-9ZWkbtzzaM},
   volume = {92},
   year = {2013}
}

TY  - JOUR
ID  - 1082993
AU  - Krejčí, Marta - Doubek, Michael - Brychtová, Yvona - Stehlíková, Olga - Chovancová, Jana - Tichý, Boris - Skuhrová Francová, Hana - Navrátil, Milan - Tomiška, Miroslav - Horký, Ondřej - Pospíšilová, Šárka - Mayer, Jiří
PY  - 2013
TI  - Fludarabine with cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with poor-risk chronic lymphocytic leukemia
JF  - Annals of hematology
VL  - 92
IS  - 2
SP  - 249-254
EP  - 249-254
PB  - Springer Verlag
SN  - 09395555
KW  - chronic lymphocytic leukemia
KW  - reduced-intensity conditioning
KW  - fludarabine
KW  - cytarabine
UR  - http://www.deepdyve.com/lp/springer-journals/fludarabine-with-cytarabine-followed-by-reduced-intensity-conditioning-9ZWkbtzzaM
L2  - http://www.deepdyve.com/lp/springer-journals/fludarabine-with-cytarabine-followed-by-reduced-intensity-conditioning-9ZWkbtzzaM
N2  - Allogeneic stem cell transplantation (SCT) is a treatment option for patients with poor-risk chronic lymphocytic leukemia (CLL).Sequential use of chemotherapy and reduced-intensity conditioning has been proposed to improve the treatment outcomes.
ER  -

KREJČÍ, Marta; Michael DOUBEK; Yvona BRYCHTOVÁ; Olga STEHLÍKOVÁ; Jana CHOVANCOVÁ; Boris TICHÝ; Hana SKUHROVÁ FRANCOVÁ; Milan NAVRÁTIL; Miroslav TOMIŠKA; Ondřej HORKÝ; Šárka POSPÍŠILOVÁ and Jiří MAYER. Fludarabine with cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with poor-risk chronic lymphocytic leukemia. \textit{Annals of hematology}. New York: Springer Verlag, 2013, vol.~92, No~2, p.~249-254. ISSN~0939-5555. Available from: https://dx.doi.org/10.1007/s00277-012-1579-y.

Přehled o publikaci